|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.42 EUR | +0.99% |
|
+1.67% | +8.97% |
| 16/07 | MWB Research Upgrades BASF to Buy, Lifts PT | MT |
| 16/07 | German chemicals lobby warns growth drift to Asia is hurting recovery | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 7.86TCr | 8.73TCr | 6.89TCr | 6.53TCr | 5.97TCr | |||||
Total Revenues | 7.86TCr | 8.73TCr | 6.89TCr | 6.53TCr | 5.97TCr | |||||
Cost of Goods Sold, Total | 5.91TCr | 6.67TCr | 5.25TCr | 4.85TCr | 4.55TCr | |||||
Gross Profit | 1.95TCr | 2.06TCr | 1.64TCr | 1.68TCr | 1.41TCr | |||||
Selling General & Admin Expenses, Total | 990.2Cr | 1.12TCr | 1.04TCr | 1.03TCr | 888.3Cr | |||||
Exploration / Drilling Costs, Total | - | - | - | - | - | |||||
Stock-Based Compensation (IS) | 3.7Cr | - | - | - | - | |||||
R&D Expenses | 221.6Cr | 229.8Cr | 213Cr | 206.1Cr | 199.5Cr | |||||
Other Operating Expenses | -12Cr | 28Cr | 101.9Cr | 148.2Cr | 78Cr | |||||
Other Operating Expenses, Total | 1.2TCr | 1.38TCr | 1.35TCr | 1.39TCr | 1.17TCr | |||||
Operating Income | 746.7Cr | 685.6Cr | 286.8Cr | 286.4Cr | 247.3Cr | |||||
Interest Expense, Total | -51Cr | -63Cr | -87Cr | -94Cr | -92Cr | |||||
Interest And Investment Income | 26Cr | 35Cr | 45Cr | 52Cr | 41Cr | |||||
Net Interest Expenses | -25Cr | -28Cr | -42Cr | -42Cr | -52Cr | |||||
Income (Loss) On Equity Invest. | 96Cr | -449.9Cr | 7.8Cr | 65Cr | 105.5Cr | |||||
Currency Exchange Gains (Loss) | -11Cr | -15Cr | -33Cr | -16Cr | -19Cr | |||||
Other Non Operating Income (Expenses) | -7.2Cr | -2Cr | -9.3Cr | 1.7Cr | 9.2Cr | |||||
EBT, Excl. Unusual Items | 799.7Cr | 190.8Cr | 211.1Cr | 295.8Cr | 291.4Cr | |||||
Restructuring Charges | -43Cr | -49Cr | -63Cr | -81Cr | -110.9Cr | |||||
Merger & Related Restructuring Charges | -2.8Cr | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | -11Cr | -11Cr | -11Cr | -12Cr | -3.3Cr | |||||
Gain (Loss) On Sale Of Assets | 13Cr | 25Cr | 4.3Cr | 3.5Cr | 67Cr | |||||
Asset Writedown | -10Cr | -38Cr | 60L | - | 80L | |||||
Insurance Settlements | - | - | - | - | - | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | 744.8Cr | 119Cr | 142Cr | 206.9Cr | 244.8Cr | |||||
Income Tax Expense | 143Cr | 158.1Cr | 104.1Cr | 62Cr | 91Cr | |||||
Earnings From Continuing Operations | 601.8Cr | -39Cr | 38Cr | 145.3Cr | 154.1Cr | |||||
Earnings Of Discontinued Operations | -3.6Cr | - | - | - | 18Cr | |||||
Net Income to Company | 598.2Cr | -39Cr | 38Cr | 145.3Cr | 172.6Cr | |||||
Minority Interest | -46Cr | -24Cr | -15Cr | -16Cr | -11Cr | |||||
Net Income - (IS) | 552.3Cr | -63Cr | 22Cr | 129.8Cr | 161.9Cr | |||||
Net Income to Common Incl Extra Items | 552.3Cr | -63Cr | 22Cr | 129.8Cr | 161.9Cr | |||||
Net Income to Common Excl. Extra Items | 555.9Cr | -63Cr | 22Cr | 129.8Cr | 143.4Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 6.01 | -0.7 | 0.25 | 1.45 | 1.82 | |||||
Basic EPS - Continuing Operations | 6.05 | -0.7 | 0.25 | 1.45 | 1.61 | |||||
Basic Weighted Average Shares Outstanding | 92Cr | 90Cr | 89Cr | 89Cr | 89Cr | |||||
Net EPS - Diluted | 6 | -0.7 | 0.25 | 1.45 | 1.81 | |||||
Diluted EPS - Continuing Operations | 6.04 | -0.7 | 0.25 | 1.45 | 1.6 | |||||
Diluted Weighted Average Shares Outstanding | 92Cr | 90Cr | 90Cr | 89Cr | 89Cr | |||||
Normalized Basic EPS | 4.94 | 1.06 | 1.31 | 1.9 | 1.92 | |||||
Normalized Diluted EPS | 4.93 | 1.06 | 1.3 | 1.89 | 1.92 | |||||
Dividend Per Share | 3.4 | 3.4 | 3.4 | 2.25 | 2.25 | |||||
Payout Ratio | 54.88 | -489.95 | 1.35T | 233.82 | 128.84 | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.1TCr | 1.02TCr | 621.3Cr | 624.4Cr | 605.3Cr | |||||
EBITA | 746.7Cr | 747.7Cr | 345Cr | 338.6Cr | 247.3Cr | |||||
EBIT | 746.7Cr | 685.6Cr | 286.8Cr | 286.4Cr | 247.3Cr | |||||
EBITDAR | 1.12TCr | 1.04TCr | 641Cr | 644.1Cr | 623.3Cr | |||||
Effective Tax Rate - (Ratio) | 19.2 | 132.86 | 73.31 | 29.77 | 37.05 | |||||
Total Current Taxes | 143.7Cr | 128.1Cr | 110.3Cr | 101.4Cr | 120.2Cr | |||||
Total Deferred Taxes | -60L | 30Cr | -6.1Cr | -40Cr | -30Cr | |||||
Normalized Net Income | 453.91Cr | 96Cr | 116.54Cr | 169.38Cr | 171.42Cr | |||||
Interest Capitalized | 2.9Cr | 4Cr | 8Cr | 15Cr | 15Cr | |||||
Interest on Long-Term Debt | 3.6Cr | 4Cr | 5.3Cr | 6.6Cr | 6.1Cr | |||||
Non-Cash Pension Expense | 50Cr | 44Cr | 32Cr | 34Cr | 22Cr | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 841.4Cr | 961.3Cr | 878.8Cr | 878.2Cr | 751.4Cr | |||||
General and Administrative Expenses | 140.8Cr | 152Cr | 150.6Cr | 146.6Cr | 133.8Cr | |||||
Research And Development Expense From Footnotes | 221.6Cr | 229.8Cr | 213Cr | 206.1Cr | 199.5Cr | |||||
Exploration/Drilling Costs | - | - | - | - | - | |||||
Net Rental Expense, Total | 19Cr | 19Cr | 20Cr | 20Cr | 18Cr | |||||
Imputed Operating Lease Interest Expense | 3.95Cr | 5.12Cr | 7.06Cr | 7.53Cr | 6.56Cr | |||||
Imputed Operating Lease Depreciation | 15Cr | 14Cr | 13Cr | 12Cr | 11Cr | |||||
Stock-Based Comp., Other (Total) | 6.4Cr | 2Cr | 2.6Cr | 2.4Cr | 2Cr | |||||
Total Stock-Based Compensation | 6.4Cr | 2Cr | 2.6Cr | 2.4Cr | 2Cr |
- Stock Market
- Stocks
- BAS Stock
- Financials BASF SE
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















